Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2022
May
09
Delfi enrolls first participants in liquid biopsy lung cancer trial
Lucid’s LucidDx Labs signs deal with MediNcrease
Mesa recalls SARS-CoV-2 tests due to contamination
Page 1 of 1